Rethinking the Utility of DDAVP for ICH Secondary to Antiplatelet Agents
A number of retrospective studies have demonstrated conflicting data regarding the association of morbidity and mortality secondary to intracerebral hemorrhage (ICH) in patients being treated with antiplatelet agents.1-4 In addition, an association between the severity of ICH as well as the conversion of a minor head trauma to an ICH secondary to the prehospital use of antiplatelet agents has yet to be determined. I was intrigued by this and evaluated a number of institutional protocols [...]